Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Holtzman

Showing results (491-500 of 554) with videos related to

Pageof 56
Sort By:
Science Advances|April 3, 2024
CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderlyFrancis Shue, Launia J White, Rachel Hendrix, et al.
Annals of Neurology|February 24, 2024
Timing of Biomarker Changes in Sporadic Alzheimer's Disease in Estimated Years from Symptom OnsetYan Li, Daniel Yen, Rachel D Hendrix, et al.
Nature Medicine|January 15, 2020
Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's diseaseYingyue Zhou, Wilbur M Song, Prabhakar S Andhey, et al.
JAMA Network Open|December 12, 2019
Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer DiseaseJorge J Llibre-Guerra, Yan Li, Suzanne E Schindler, et al.
Nature Medicine|May 16, 2020
Author Correction: Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's diseaseYingyue Zhou, Wilbur M Song, Prabhakar S Andhey, et al.
JCI Insight|May 2, 2023
KATP channels are necessary for glucose-dependent increases in amyloid-β and Alzheimer's disease-related pathologyJohn Grizzanti, William R Moritz, Morgan C Pait, et al.
BMC Neurology|December 15, 2006
Analysis of IFT74 as a candidate gene for chromosome 9p-linked ALS-FTDParastoo Momeni, Jennifer Schymick, Shushant Jain, et al.
Brain : a Journal of Neurology|August 14, 2016
BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's diseaseYen Ying Lim, Jason Hassenstab, Carlos Cruchaga, et al.
Science Translational Medicine|April 3, 2024
Antibody-mediated targeting of human microglial leukocyte Ig-like receptor B4 attenuates amyloid pathology in a mouse modelJinchao Hou, Yun Chen, Zhangying Cai, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 16, 2024
Clinical validation of the PrecivityAD2 blood test: A mass spectrometry-based test with algorithm combining %p-tau217 and Aβ42/40 ratio to identify presence of brain amyloidMatthew R Meyer, Kristopher M Kirmess, Stephanie Eastwood, et al.
Pageof 56

Showing results (491-500 of 554) with videos related to

Sort By:
Pageof 56
Science Advances|April 3, 2024
CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderlyFrancis Shue, Launia J White, Rachel Hendrix, et al.
Annals of Neurology|February 24, 2024
Timing of Biomarker Changes in Sporadic Alzheimer's Disease in Estimated Years from Symptom OnsetYan Li, Daniel Yen, Rachel D Hendrix, et al.
Nature Medicine|January 15, 2020
Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's diseaseYingyue Zhou, Wilbur M Song, Prabhakar S Andhey, et al.
JAMA Network Open|December 12, 2019
Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer DiseaseJorge J Llibre-Guerra, Yan Li, Suzanne E Schindler, et al.
Nature Medicine|May 16, 2020
Author Correction: Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's diseaseYingyue Zhou, Wilbur M Song, Prabhakar S Andhey, et al.
JCI Insight|May 2, 2023
KATP channels are necessary for glucose-dependent increases in amyloid-β and Alzheimer's disease-related pathologyJohn Grizzanti, William R Moritz, Morgan C Pait, et al.
BMC Neurology|December 15, 2006
Analysis of IFT74 as a candidate gene for chromosome 9p-linked ALS-FTDParastoo Momeni, Jennifer Schymick, Shushant Jain, et al.
Brain : a Journal of Neurology|August 14, 2016
BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's diseaseYen Ying Lim, Jason Hassenstab, Carlos Cruchaga, et al.
Science Translational Medicine|April 3, 2024
Antibody-mediated targeting of human microglial leukocyte Ig-like receptor B4 attenuates amyloid pathology in a mouse modelJinchao Hou, Yun Chen, Zhangying Cai, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 16, 2024
Clinical validation of the PrecivityAD2 blood test: A mass spectrometry-based test with algorithm combining %p-tau217 and Aβ42/40 ratio to identify presence of brain amyloidMatthew R Meyer, Kristopher M Kirmess, Stephanie Eastwood, et al.
Pageof 56